Clinical Differences That Matter for Your Choice
Is Mounjaro or Wegovy Better for UK Availability and Stock Levels?
Both Mounjaro and Wegovy are currently available in stock at EverydayMeds across all licensed doses, addressing previous supply concerns that affected the UK market. Wegovy's supply chain from Novo Nordisk has stabilised significantly, with consistent stock levels maintained for the 0.25mg starter dose through to the 2.4mg maintenance dose. This means patients can begin treatment immediately without joining waiting lists or experiencing treatment interruptions that were common during 2022-2023 supply shortages.
When considering is Mounjaro or Wegovy better from a practical availability perspective, both medications can be ordered today with next-day delivery once your prescription is approved by our clinical team. EverydayMeds maintains strategic stock levels of both treatments, ensuring continuity of supply for patients progressing through dose escalation schedules. Our GPhC-registered pharmacy (#9012878) processes orders with same reliability for both medications, removing availability as a deciding factor between the treatments.
Wegovy vs Mounjaro Pricing and Value Comparison in the UK
Understanding the cost implications helps determine is Mounjaro or Wegovy better for your budget and treatment duration. Wegovy pricing at EverydayMeds starts at £79.99 for the 0.25mg starter dose (weeks 1-4) after applying discount code FIRST40 for new customers, progressing to £94.99 for 0.5mg (weeks 5-8), £99.99 for 1mg (weeks 9-12), £139.99 for 1.7mg (weeks 13-16), and £209.99 for the 2.4mg maintenance dose. Bundle options provide convenient multi-dose packages, such as the Intro Trio (0.25mg, 0.5mg, and 1mg) for £299.99, supporting the essential dose escalation protocol.
Both medications require similar dose escalation approaches, meaning total treatment costs follow comparable patterns over the initial 16-week titration period. Returning customers benefit from code DOSE25 at checkout, maintaining affordability for long-term weight management commitment. The pricing structure reflects the prescription-only medicine status of both treatments, with clinical assessment and prescriber review ensuring appropriate candidacy before dispensing either Mounjaro or Wegovy.
Clinical Evidence: Is Mounjaro or Wegovy Better According to Research?
Determining is Mounjaro or Wegovy better requires examining their distinct clinical trial programmes, though direct head-to-head comparisons aren't available due to different study designs and patient populations. Wegovy demonstrated significant efficacy in the STEP trial programme, with STEP 1 showing an average 14.9% weight reduction at 68 weeks compared to 2.4% with placebo when combined with lifestyle interventions (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial further demonstrated a 20% reduction in major adverse cardiovascular events with Wegovy treatment.
Mounjaro's clinical evidence comes from the SURMOUNT trials, which evaluated tirzepatide's dual GIP and GLP-1 receptor agonism mechanism. Both medications require prescription alongside reduced-calorie diet and increased physical activity, with individual response varying based on patient factors including baseline BMI, comorbidities, and adherence to lifestyle modifications. Your prescriber can evaluate which clinical profile aligns better with your specific health circumstances.
How Wegovy Works: Understanding the GLP-1 Mechanism
When evaluating is Mounjaro or Wegovy better, understanding Wegovy's mechanism helps inform treatment selection. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural incretin hormone GLP-1 produced in your intestines after eating. This mechanism reduces appetite by acting on brain centres that control hunger and satiety, promoting feelings of fullness after smaller meal portions. The once-weekly injection using the FlexTouch pen device provides sustained appetite regulation throughout the seven-day dosing interval. Wegovy may also slow gastric emptying, contributing to prolonged satiety signals that support adherence to reduced-calorie dietary plans essential for successful weight management outcomes.
Streamlined Ordering Process for Both Mounjaro and Wegovy
The ordering process remains identical whether you're prescribed Mounjaro or Wegovy, removing procedural complexity from the is Mounjaro or Wegovy better decision. Begin with our 3-minute online clinical assessment covering medical history, current medications, weight management goals, and relevant health conditions that influence treatment suitability. Our clinical team reviews applications within 3 working days (or 24 hours with express service), ensuring thorough evaluation of your candidacy for either prescription-only medicine. Once approved, your chosen medication ships via next-day cold-chain delivery, maintaining the 2-8°C temperature requirements throughout transit. This streamlined process applies equally to both treatments, with clinical assessment determining the most appropriate option based on your individual health profile and treatment objectives.
Storage and Practical Considerations: Mounjaro vs Wegovy
Storage requirements may influence is Mounjaro or Wegovy better for your lifestyle and travel needs. Both medications require refrigeration at 2-8°C before first use, but Wegovy offers superior room temperature stability once removed from the fridge. Wegovy pens can remain at room temperature (below 30°C) for up to 6 weeks, compared to Mounjaro's 21-day room temperature limit. This storage advantage makes Wegovy more suitable for frequent travellers or those with limited refrigeration access. Both treatments follow similar dose escalation protocols starting at the lowest dose and increasing every 4 weeks, requiring consistent medication supply and adherence to the prescribed schedule. The FlexTouch pen design for Wegovy provides intuitive injection technique, while both medications require weekly administration on the same day each week.
Supply Chain Reliability: Why Both Treatments Are Available Now
Previous supply disruptions that affected the UK weight management market have been resolved, making is Mounjaro or Wegovy better a clinical rather than availability question. EverydayMeds maintains robust stock levels for both medications through established relationships with Novo Nordisk (Wegovy) and Eli Lilly (Mounjaro), ensuring consistent supply even during periods of increased demand. Our inventory management systems monitor stock levels across all doses, preventing treatment interruptions that could compromise your weight management progress.
This supply reliability means you can focus on clinical suitability rather than availability when determining is Mounjaro or Wegovy better for your needs. Both medications are manufactured by leading pharmaceutical companies with established UK distribution networks, supported by MHRA licensing and quality assurance protocols. Our GPhC-registered pharmacy status (#9012878) ensures compliance with UK pharmaceutical regulations for both treatments, providing confidence in medication quality and authenticity regardless of which prescription-only medicine your clinical team recommends.
Making Your Decision: Clinical Assessment Determines the Best Choice
Rather than definitively answering is Mounjaro or Wegovy better, the optimal choice depends on your individual clinical profile, treatment goals, and practical considerations evaluated during your prescription consultation. Both Wegovy and Mounjaro are available from EverydayMeds, with your prescriber helping determine which treatment aligns with your health circumstances, medication tolerance, and weight management objectives. Factors including your BMI, existing health conditions, current medications, and previous weight loss attempts influence treatment selection beyond simple medication comparison. Start your clinical assessment today using discount code FIRST40 for new customers or DOSE25 for returning patients, beginning your journey toward effective weight management with professional clinical support. Visit https://everydaymeds.co.uk/collections/wegovy to begin your assessment and discover which prescription-only medicine offers the best foundation for your long-term health goals.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
